Syringes Market by Product (General Syringes, Specialized Syringes, and Others), Usage (Reusable and Disposable Syringes), Material (Glass and Polymer), and End Use (Hospitals, Diagnostic Centers, Speciality Centers, and Others): Global Opportunity Analysis and Industry Forecast, 2020–2027
- ALL4209062
- 254 Pages
- December 2020
- Medical Devices
A syringe is a cylindrical medical device, which is equipped with a thin hollow needle at the end attached to a tube and a plunger. When the plunger handle is pulled back, fluids are drawn into the tube. The fluid is forced out through the needle when the handle is pushed down. Syringes are used for the extraction of fluids from the body or inject fluids into the body. Different types of syringes are available in the market, which include general syringe, specialized syringes (insulin syringe, tuberculin syringe), and disposable syringes (conventional syringes, prefilled syringes, and safety syringes). The disposable syringes production line is manufactured with the use of polypropylene, and are intended for single use. These are used in research laboratories, diagnostic centers, medical and veterinary science, and for the injection of medicines and vaccines. Disposable syringes are rapidly replacing glass syringes due to their availability in sterilized condition, ready-to-use form, and cost effectiveness.
Furthermore, mandatory recommendation by WHO to switch to disposable syringes ensuring safe injection practices, resulting in increased use of disposable syringes. In addition, WHO launched a new policy in 2015 on safety injection to tackle the pervasive concern of unsafe injections across the globe. As per WHO, a large part of the global population could be protected from the life-threatening infectious diseases acquired by the use of unsafe injections if reuse of syringes is avoided significantly fosters the growth of the syringes market. The adoption of safety syringes have been witnessed to be increasing across the globe, due to rise in cases of needlestick injuries. However, prefilled syringes are expected to accelerate over the coming decades. They are generally preferred for parenteral administration of various drugs, minimizing drug waste, increasing product life span, and greater dose precision are some of the driving factors boosting the market demand. According to the Occupational Safety and Health Administration (OSHA) estimates, approximately 5.6 million healthcare professionals were susceptible to blood-borne diseases in 2014, owing to rise in prevalence of needlestick and other sharps object injuries. Every year, about 384,000 healthcare personnel suffer from needlestick injuries in the U.S. Thus, such alarming increase in incidence of needlestick injuries has created an impending need for safety syringes. In addition,
Increase in usage of injectable drug delivery devices, technological advancements in syringe, upsurge in geriatric population, alarming rise in incidence of chronic diseases, and increase in the number of cosmetic procedures are the key factors that boost the growth of the syringes market. Moreover, wide availability of cost-effective safety syringes, and increase in number of surgeries among the elderly population drive the growth of the market. However, availability of alternative ways of drug delivery is anticipated to restrain market growth.
The syringes market is segmented into type, usage, material, end use, and region. Depending on type, the market is categorized into general syringes, specialized syringes, and others. The specialized syringes are further bifurcated into insulin syringes and tuberculin syringes. As per usage, the market is segregated into reusable and disposable syringes. The disposable syringes segment is further divided into conventional syringes, prefilled syringes, and safety syringes. The material segment is divided into glass and polymer.
On the basis of end user, it is differentiated into hospitals, diagnostic centers, speciality centers, and others
Region wise, the market is analyzed across North America Europe, Asia-Pacific, and LAMEA.
KEY BENEFITS FOR STAKEHOLDERS
• The study provides an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets.
• It offers a quantitative analysis from 2019 to 2027, which is expected to enable the stakeholders to capitalize on the prevailing market opportunities.
• A comprehensive analysis of major regions is provided to determine the existing opportunities.
• The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global market.
KEY MARKET SEGMENTS
By Product
• General Syringe
• Specialized Syringes
o Insulin Syringe
o Tuberculin Syringe
• Others
By Usage
• Reusable Syringes
• Disposable Syringes
o Conventional syringes
o Prefilled syringes
o Safety syringes
By Material
• Glass
• Polymer
By End Use
• Hospitals
• Diagnostic centers
• Speciality centers
• Others
By Region
• North America
o U.S.
o Canada
o Mexico
• Europe
o Germany
o France
o UK
o Italy
o Spain
o Rest of Europe
• Asia-Pacific
o China
o Japan
o
o India
o Australia
o South Korea
o Rest of Asia-Pacific
• LAMEA
o Brazil
o Saudi Arabia
o South Africa
o Rest of LAMEA
LIST OF KEY PLAYERS PROFILED IN THE REPORT
• B. Braun Melsungen AG
• Becton, Dickinson and Company
• Cardinal Health Inc
• Gerresheimer AG
• Hindustan Syringes and Medical Devices Ltd.
• Medline Industries, Inc
• Nipro Corporation (Nipro Medical Corporation)
• Retractable Technologies. Inc
• Smith’s Group Plc
• Terumo Corporation (Terumo Medical Corporation)
LIST OF OTHER PLAYERS IN THE VALUE CHAIN (These players are not profiled in the report. The same will be included on request.)
• SCHOTT AG
• Codan Medizinische Geräte GmbH & Co Kg
1.1.Report description
1.2.Key market segments
1.2.1.List of key players profiled in the report
1.3.Research methodology
1.3.1.Primary research
1.3.2.Secondary research
1.3.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.1.1.Top investment pockets
3.1.2.Top winning strategies
3.2.Porter’s five forces analysis
3.3.Market share analysis
3.4.Market dynamics
3.4.1.Drivers
3.4.1.1.Upsurge in incidence of needlestick injuries
3.4.1.2.Increase in awareness of smart syringes
3.4.1.3.Technological advancements
3.4.2.Restraints
3.4.2.1.High cost and unaffordability of safety syringes
3.4.2.2.Alternative modes of drug delivery
3.4.3.Opportunity
3.4.3.1.Rise in need for safety syringes in emerging economies
3.4.4.Impact Analyses
3.5.Impact Analysis of COVID-19 on Syringes Market
CHAPTER 4:SYRINGES MARKET, BY PRODUCT
4.1.Overview
4.1.1.Market size and forecast
4.2.General Syringes
4.2.1.Key findings and opportunity
4.2.2.Market size and forecast, by region
4.2.3.Market analysis by country
4.3.Specialized Syringes
4.3.1.Key findings and opportunity
4.3.2.Market size and forecast, by region
4.3.3.Market analysis by country
4.3.3.1.Insulin Syringes
4.3.3.1.1.Market size and forecast
4.3.3.2.Tuberculin Syringe
4.3.3.2.1.Market size and forecast
4.4.Others
4.4.1.Key findings and opportunity
4.4.2.Market size and forecast, by region
4.4.3.Market analysis by country
CHAPTER 5:SYRINGES MARKET, BY USAGE
5.1.Overview
5.1.1.Market size and forecast
5.2.Disposable syringes
5.2.1.Market size and forecast, by region
5.2.2.Market analysis by country
5.2.2.1.Conventional syringes
5.2.2.1.1.Market size and forecast
5.2.2.2.Safety syringes
5.2.2.2.1.Market size and forecast
5.2.2.3.Prefilled syringes
5.2.2.3.1.Market size and forecast
5.3.Reusable Syringes
5.3.1.Market size and forecast, by region
5.3.2.Market analysis by country
CHAPTER 6:SYRINGES MARKET, BY MATERIAL
6.1.Overview
6.1.1.Market size and forecast
6.2.Glass
6.2.1.Market size and forecast, by region
6.2.2.Market analysis by country
6.3.Polymer
6.3.1.Market size and forecast, by region
6.3.2.Market analysis by country
CHAPTER 7:SYRINGES MARKET, BY END USE
7.1.Overview
7.1.1.Market size and forecast
7.2.Hospitals
7.2.1.Market size and forecast, by region
7.2.2.Market analysis by country
7.3.Diagnostic Centers
7.3.1.Market size and forecast, by region
7.3.2.Market analysis by country
7.4.Speciality centers
7.4.1.Market size and forecast, by region
7.4.2.Market analysis by country
7.5.Others
7.5.1.Market size and forecast, by region
7.5.2.Market analysis by country
CHAPTER 8:SYRINGES MARKET, BY REGION
8.1.Overview
8.1.1.Market size and forecast
8.2.North America
8.2.1.Key market trends and opportunities
8.2.2.North America cell culture market, by country
8.2.2.1.U.S. syringes market, by product
8.2.2.2.U.S. syringes market, by usage
8.2.2.3.U.S. syringes market, by material
8.2.2.4.U.S. syringes market, by end use
8.2.2.5.Canada syringes market, by product
8.2.2.6.Canada syringes market, by usage
8.2.2.7.Canada syringes market, by material
8.2.2.8.Canada syringes market, by end use
8.2.2.9.Mexico syringes market, by product
8.2.2.10.Mexico syringes market, by usage
8.2.2.11.Mexico syringes market, by material
8.2.2.12.Mexico syringes market, by end use
8.2.3.North America syringes market, by product type
8.2.4.North America syringes market, by usage
8.2.5.North America syringes market, by material
8.2.6.North America syringes market, by end use
8.3.Europe
8.3.1.Key market trends and opportunities
8.3.2.Europe syringes market, by country
8.3.2.1.Germany syringes market, by product
8.3.2.2.Germany syringes market, by usage
8.3.2.3.Germany syringes market, by material
8.3.2.4.Germany syringes market, by end use
8.3.2.5.France syringes market, by product
8.3.2.6.France syringes market, by usage
8.3.2.7.France syringes market, by material
8.3.2.8.France syringes market, by end use
8.3.2.9.UK syringes market, by product
8.3.2.10.UK syringes market, by usage
8.3.2.11.UK syringes market, by material
8.3.2.12.UK syringes market, by end use
8.3.2.13.Italy syringes market, by product
8.3.2.14.Italy syringes market, by usage
8.3.2.15.Italy syringes market, by material
8.3.2.16.Italy syringes market, by end use
8.3.2.17.Spain syringes market, by product
8.3.2.18.Spain syringes market, by usage
8.3.2.19.Spain syringes market, by material
8.3.2.20.Spain syringes market, by end use
8.3.2.21.Rest of Europe syringes market, by product
8.3.2.22.Rest of Europe syringes market, by usage
8.3.2.23.Rest of Europe syringes market, by material
8.3.2.24.Rest of Europe syringes market, by end use
8.3.3.Europe Syringes market, by product
8.3.4.Europe syringes market, by usage
8.3.5.Europe syringes market, by material
8.3.6.Europe syringes market, by end use
8.4.Asia-Pacific
8.4.1.Key market trends and opportunities
8.4.2.Asia-Pacific syringes market, by country
8.4.2.1.China syringes market, by product
8.4.2.2.China syringes market, by usage
8.4.2.3.China syringes market, by material
8.4.2.4.China syringes market, by end use
8.4.2.5.Japan syringes market, by product
8.4.2.6.Japan syringes market, by usage
8.4.2.7.Japan syringes market, by material
8.4.2.8.Japan syringes market, by end use
8.4.2.9.India syringes market, by product
8.4.2.10.India syringes market, by usage
8.4.2.11.India syringes market, by material
8.4.2.12.India syringes market, by end use
8.4.2.13.Australia syringes market, by product
8.4.2.14.Australia syringes market, by usage
8.4.2.15.Australia syringes market, by material
8.4.2.16.Australia syringes market, by end use
8.4.2.17.South Korea syringes market, by product
8.4.2.18.South Korea syringes market, by usage
8.4.2.19.South Korea syringes market, by material
8.4.2.20.South Korea syringes market, by end use
8.4.2.21.Rest of Asia-Pacific syringes market, by product
8.4.2.22.Rest of Asia-Pacific syringes market, by usage
8.4.2.23.Rest of Asia-Pacific syringes market, by material
8.4.2.24.Rest of Asia-Pacific syringes market, by end use
8.4.3.Asia-Pacific syringes market, by product
8.4.4.Asia-Pacific syringes market, by usage
8.4.5.Asia-Pacific syringes market, by material
8.4.6.Asia-Pacific syringes market, by end use
8.5.LAMEA
8.5.1.Key market trends and opportunities
8.5.2.LAMEA syringes market, by country
8.5.2.1.Brazil syringes market, by product
8.5.2.2.Brazil syringes market, by usage
8.5.2.3.Brazil syringes market, by material
8.5.2.4.Brazil syringes market, by end use
8.5.2.5.Saudi Arabia syringes market, by product
8.5.2.6.Saudi Arabia syringes market, by usage
8.5.2.7.Saudi Arabia syringes market, by material
8.5.2.8.Saudi Arabia syringes market, by end use
8.5.2.9.South Africa syringes market, by product
8.5.2.10.South Africa syringes market, by usage
8.5.2.11.South Africa syringes market, by material
8.5.2.12.South Africa syringes market, by end use
8.5.2.13.Rest of LAMEA syringes market, by product
8.5.2.14.Rest of LAMEA syringes market, by usage
8.5.2.15.Rest of LAMEA syringes market, by material
8.5.2.16.Rest of LAMEA syringes market, by end use
8.5.3.LAMEA syringes market, by product
8.5.4.LAMEA syringes market, by usage
8.5.5.LAMEA syringes market, by material
8.5.6.LAMEA syringes market, by end use
CHAPTER 9:COMPANY PROFILES
9.1.B. Braun Melsungen AG
9.1.1.Company overview
9.1.2.Company snapshot
9.1.3.Operating business segments
9.1.4.Product portfolio
9.1.5.Business performance
9.2.Becton, Dickinson and Company
9.2.1.Company overview
9.2.2.Company snapshot
9.2.3.Operating business segments
9.2.4.Product portfolio
9.2.5.Business performance
9.3.Cardinal Health Inc.
9.3.1.Company overview
9.3.2.Company snapshot
9.3.3.Operating business segments
9.3.4.Product portfolio
9.3.5.Business performance
9.4.Gerresheimer AG
9.4.1.Company overview
9.4.2.Company snapshot
9.4.3.Operating business segments
9.4.4.Product portfolio
9.4.5.Business performance
9.5.Hindustan Syringes and Medical Devices Ltd.
9.5.1.Company overview
9.5.2.Company snapshot
9.5.3.Product portfolio
9.6.Medline Industries, Inc.
9.6.1.Company overview
9.6.2.Company snapshot
9.6.3.Operating business segments
9.6.4.Product portfolio
9.7.Nipro Corporation (Nipro Medical Corporation)
9.7.1.Company overview
9.7.2.Company snapshot
9.7.3.Operating business segments
9.7.4.Product portfolio
9.7.5.Business performance
9.8.Retractable Technologies, Inc
9.8.1.Company overview
9.8.2.Company snapshot
9.8.3.Product portfolio
9.8.4.Business performance
9.9.Smith’s Group Plc
9.9.1.Company overview
9.9.2.Company snapshot
9.9.3.Operating business segments
9.9.4.Product portfolio
9.9.5.Business performance
9.10.Terumo Corporation (Terumo Medical Corporation)
9.10.1.Company overview
9.10.2.Company snapshot
9.10.3.Operating business segments
9.10.4.Product portfolio
9.10.5.Business performance
TABLE 01.SYRINGES MARKET, BY PRODUCT, 2019-2027 ($MILLION)
TABLE 02.GENERAL SYRINGES MARKET BY REGION 2019-2027, ($MILLION)
TABLE 03.SPECIALIZED SYRINGES MARKET BY REGION2019-2027, ($MILLION)
TABLE 04.OTHERS SYRINGE MARKET BY REGION 2019-2027, ($MILLION)
TABLE 05.SYRINGES MARKET, BY USAGE, 2019-2027 ($MILLION)
TABLE 06.DISPOSABLE SYRINGES MARKET BY REGION 2019-2027, ($MILLION)
TABLE 07.REUSABLE SYRINGES MARKET BY REGION2019-2027, ($MILLION)
TABLE 08.SYRINGES MARKET, BY MATERIAL, 2019-2027 ($MILLION)
TABLE 09.GLASS SYRINGES MARKET BY REGION 2019-2027, ($MILLION)
TABLE 10.POLYMER SYRINGES MARKET BY REGION2019-2027, ($MILLION)
TABLE 11.SYRINGES MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 12.SYRINGES MARKET FOR HOSPITALS, BY REGION 2019–2027($MILLION)
TABLE 13.SYRINGES MARKET FOR DIAGNOSTIC CENTERS, BY REGION 2019–2027 ($MILLION)
TABLE 14.SYRINGES MARKET FOR SPECIALITY CENTERS, BY REGION 2019–2027 ($MILLION)
TABLE 15.SYRINGES MARKET FOR OTHERS, BY REGION 2019–2027 ($MILLION)
TABLE 16.SYRINGES MARKET REVENUE, BY REGION, 2019–2027($MILLION)
TABLE 17.NORTH AMERICA SYRINGES MARKET, BY COUNTRY, 2019–2027($MILLION)
TABLE 18.U.S. SYRINGES MARKET, BY PRODUCT, 2019–2027($MILLION)
TABLE 19.U.S. SYRINGES MARKET, BY USAGE, 2019–2027($MILLION)
TABLE 20.U.S. SYRINGES MARKET, BY MATERIAL, 2019–2027($MILLION)
TABLE 21.U.S. SYRINGES MARKET, BY END USE, 2019–2027($MILLION)
TABLE 22.CANADA SYRINGES MARKET, BY PRODUCT, 2019–2027($MILLION)
TABLE 23.CANADA SYRINGES MARKET, BY USAGE, 2019–2027($MILLION)
TABLE 24.CANADA SYRINGES MARKET, BY MATERIAL, 2019–2027($MILLION)
TABLE 25.CANADA SYRINGES MARKET, BY END USE, 2019–2027($MILLION)
TABLE 26.MEXICO MARKET, BY PRODUCT, 2019–2027($MILLION)
TABLE 27.MEXICO SYRINGES MARKET, BY USAGE, 2019–2027($MILLION)
TABLE 28.MEXICO SYRINGES MARKET, BY MATERIAL, 2019–2027($MILLION)
TABLE 29.MEXICO SYRINGES MARKET, BY END USE, 2019–2027($MILLION)
TABLE 30.NORTH AMERICA MARKET, BY PRODUCT, 2019–2027($MILLION)
TABLE 31.NORTH AMERICA SYRINGES MARKET, BY USAGE, 2019–2027($MILLION)
TABLE 32.NORTH AMERICA SYRINGES MARKET, BY MATERIAL, 2019–2027($MILLION)
TABLE 33.NORTH AMERICA SYRINGES MARKET, BY END USE, 2019–2027($MILLION)
TABLE 34.EUROPE SYRINGES MARKET, BY COUNTRY, 2019–2027($MILLION)
TABLE 35.GERMANY SYRINGES MARKET, BY PRODUCT, 2019–2027($MILLION)
TABLE 36.GERMANY SYRINGES MARKET, BY USAGE, 2019–2027($MILLION)
TABLE 37.GERMANY SYRINGES MARKET, BY MATERIAL, 2019–2027($MILLION)
TABLE 38.GERMANY SYRINGES MARKET, BY END USE, 2019–2027($MILLION)
TABLE 39.FRANCE SYRINGES MARKET, BY PRODUCT, 2019–2027($MILLION)
TABLE 40.FRANCE SYRINGES MARKET, BY USAGE, 2019–2027($MILLION)
TABLE 41.FRANCE SYRINGES MARKET, BY MATERIAL, 2019–2027($MILLION)
TABLE 42.FRANCE SYRINGES MARKET, BY END USE, 2019–2027($MILLION)
TABLE 43.UK MARKET, BY PRODUCT, 2019–2027($MILLION)
TABLE 44.UK SYRINGES MARKET, BY USAGE, 2019–2027($MILLION)
TABLE 45.UK SYRINGES MARKET, BY MATERIAL, 2019–2027($MILLION)
TABLE 46.UK SYRINGES MARKET, BY END USE, 2019–2027($MILLION)
TABLE 47.ITALY MARKET, BY PRODUCT, 2019–2027($MILLION)
TABLE 48.ITALY SYRINGES MARKET, BY USAGE, 2019–2027($MILLION)
TABLE 49.ITALY SYRINGES MARKET, BY MATERIAL, 2019–2027($MILLION)
TABLE 50.ITALY SYRINGES MARKET, BY END USE, 2019–2027($MILLION)
TABLE 51.SPAIN MARKET, BY PRODUCT, 2019–2027($MILLION)
TABLE 52.SPAIN SYRINGES MARKET, BY USAGE, 2019–2027($MILLION)
TABLE 53.SPAIN SYRINGES MARKET, BY MATERIAL, 2019–2027($MILLION)
TABLE 54.SPAIN SYRINGES MARKET, BY END USE, 2019–2027($MILLION)
TABLE 55.REST OF EUROPE MARKET, BY PRODUCT, 2019–2027($MILLION)
TABLE 56.REST OF EUROPE SYRINGES MARKET, BY USAGE, 2019–2027($MILLION)
TABLE 57.REST OF EUROPE SYRINGES MARKET, BY MATERIAL, 2019–2027($MILLION)
TABLE 58.REST OF EUROPE SYRINGES MARKET, BY END USE, 2019–2027($MILLION)
TABLE 59.EUROPE SYRINGES MARKET, BY PRODUCT, 2019–2027($MILLION)
TABLE 60.EUROPE SYRINGES MARKET, BY USAGE, 2019–2027($MILLION)
TABLE 61.EUROPE SYRINGES MARKET, BY MATERIAL, 2019–2027($MILLION)
TABLE 62.EUROPE SYRINGES MARKET, BY END USE, 2019–2027($MILLION)
TABLE 63.ASIA-PACIFIC SYRINGES MARKET, BY COUNTRY, 2019–2027($MILLION)
TABLE 64.CHINA SYRINGES MARKET, BY PRODUCT, 2019–2027($MILLION)
TABLE 65.CHINA SYRINGES MARKET, BY USAGE, 2019–2027($MILLION)
TABLE 66.CHINA SYRINGES MARKET, BY MATERIAL, 2019–2027($MILLION)
TABLE 67.CHINA SYRINGES MARKET, BY END USE, 2019–2027($MILLION)
TABLE 68.JAPAN SYRINGES MARKET, BY PRODUCT, 2019–2027($MILLION)
TABLE 69.JAPAN SYRINGES MARKET, BY USAGE, 2019–2027($MILLION)
TABLE 70.JAPAN SYRINGES MARKET, BY MATERIAL, 2019–2027($MILLION)
TABLE 71.JAPAN SYRINGES MARKET, BY END USE, 2019–2027($MILLION)
TABLE 72.INDIA MARKET, BY PRODUCT, 2019–2027($MILLION)
TABLE 73.INDIA SYRINGES MARKET, BY USAGE, 2019–2027($MILLION)
TABLE 74.INDIA SYRINGES MARKET, BY MATERIAL, 2019–2027($MILLION)
TABLE 75.INDIA SYRINGES MARKET, BY END USE, 2019–2027($MILLION)
TABLE 76.AUSTRALIA MARKET, BY PRODUCT, 2019–2027($MILLION)
TABLE 77.AUSTRALIA SYRINGES MARKET, BY USAGE, 2019–2027($MILLION)
TABLE 78.AUSTRALIA SYRINGES MARKET, BY MATERIAL, 2019–2027($MILLION)
TABLE 79.AUSTRALIA SYRINGES MARKET, BY END USE, 2019–2027($MILLION)
TABLE 80.SOUTH KOREA SYRINGES MARKET, BY PRODUCT, 2019–2027($MILLION)
TABLE 81.SOUTH KOREA SYRINGES MARKET, BY USAGE, 2019–2027($MILLION)
TABLE 82.SOUTH KOREA SYRINGES MARKET, BY MATERIAL, 2019–2027($MILLION)
TABLE 83.SOUTH KOREA SYRINGES MARKET, BY END USE, 2019–2027($MILLION)
TABLE 84.REST OF ASIA-PACIFIC MARKET, BY PRODUCT, 2019–2027($MILLION)
TABLE 85.REST OF ASIA-PACIFIC SYRINGES MARKET, BY USAGE, 2019–2027($MILLION)
TABLE 86.REST OF ASIA-PACIFIC SYRINGES MARKET, BY MATERIAL, 2019–2027($MILLION)
TABLE 87.REST OF ASIA-PACIFIC SYRINGES MARKET, BY END USE, 2019–2027($MILLION)
TABLE 88.ASIA-PACIFIC SYRINGES MARKET, BY PRODUCT, 2019–2027($MILLION)
TABLE 89.ASIA-PACIFIC SYRINGES MARKET, BY USAGE, 2019–2027($MILLION)
TABLE 90.ASIA-PACIFIC SYRINGES MARKET, BY MATERIAL, 2019–2027($MILLION)
TABLE 91.ASIA-PACIFIC SYRINGES MARKET, BY END USE, 2019–2027($MILLION)
TABLE 92.LAMEA SYRINGES MARKET, BY COUNTRY, 2019–2027($MILLION)
TABLE 93.BRAZIL SYRINGES MARKET, BY PRODUCT, 2019–2027($MILLION)
TABLE 94.BRAZIL SYRINGES MARKET, BY USAGE, 2019–2027($MILLION)
TABLE 95.BRAZIL SYRINGES MARKET, BY MATERIAL, 2019–2027($MILLION)
TABLE 96.BRAZIL SYRINGES MARKET, BY END USE, 2019–2027($MILLION)
TABLE 97.SAUDI ARABIA MARKET, BY PRODUCT, 2019–2027($MILLION)
TABLE 98.SAUDI ARABIA SYRINGES MARKET, BY USAGE, 2019–2027($MILLION)
TABLE 99.SAUDI ARABIA SYRINGES MARKET, BY MATERIAL, 2019–2027($MILLION)
TABLE 100.SAUDI ARABIA SYRINGES MARKET, BY END USE, 2019–2027($MILLION)
TABLE 101.SOUTH AFRICA MARKET, BY PRODUCT, 2019–2027($MILLION)
TABLE 102.SOUTH AFRICA SYRINGES MARKET, BY USAGE, 2019–2027($MILLION)
TABLE 103.SOUTH AFRICA SYRINGES MARKET, BY MATERIAL, 2019–2027($MILLION)
TABLE 104.SOUTH AFRICA SYRINGES MARKET, BY END USE, 2019–2027($MILLION)
TABLE 105.REST OF LAMEA MARKET, BY PRODUCT, 2019–2027($MILLION)
TABLE 106.REST OF LAMEA SYRINGES MARKET, BY USAGE, 2019–2027($MILLION)
TABLE 107.REST OF LAMEA SYRINGES MARKET, BY MATERIAL, 2019–2027($MILLION)
TABLE 108.REST OF LAMEA SYRINGES MARKET, BY END USE, 2019–2027($MILLION)
TABLE 109.LAMEA SYRINGES MARKET, BY PRODUCT, 2019–2027($MILLION)
TABLE 110.LAMEA SYRINGES MARKET, BY USAGE, 2019–2027($MILLION)
TABLE 111.LAMEA SYRINGES MARKET, BY MATERIAL, 2019–2027($MILLION)
TABLE 112.LAMEA SYRINGES MARKET, BY END USE, 2019–2027($MILLION)
TABLE 113.B. BRAUN: COMPANY SNAPSHOT
TABLE 114.B. BRAUN: BUSINESS SEGMENTS
TABLE 115.B. BRAUN: PRODUCT PORTFOLIO
TABLE 116.BD: SNAPSHOT
TABLE 117.BD: OPERATING SEGMENTS
TABLE 118.BD: PRODUCT PORTFOLIO
TABLE 119.CARDINAL HEALTH: COMPANY SNAPSHOT
TABLE 120.CARDINAL HEALTH: OPERATING SEGMENTS
TABLE 121.CARDINAL HEALTH: PRODUCT PORTFOLIO
TABLE 122.GERRESHEIMER: SNAPSHOT
TABLE 123.GERRESHEIMER: OPERATING SEGMENTS
TABLE 124.GERRESHEIMER: PRODUCT PORTFOLIO
TABLE 125.HMD: SNAPSHOT
TABLE 126.HMD: PRODUCT PORTFOLIO
TABLE 127.MEDLINE: SNAPSHOT
TABLE 128.MEDLINE: OPERATING SEGMENTS
TABLE 129.MEDLINE: PRODUCT PORTFOLIO
TABLE 130.NIPRO GROUP: SNAPSHOT
TABLE 131.NIPRO GROUP: OPERATING SEGMENTS
TABLE 132.NIPRO GROUP: PRODUCT PORTFOLIO
TABLE 133.RETRACTABLE: COMPANY SNAPSHOT
TABLE 134.RETRACTABLE: PRODUCT PORTFOLIO
TABLE 135.SMITHS MEDICAL: COMPANY SNAPSHOT
TABLE 136.SMITHS MEDICAL: OPERATING SEGMENTS
TABLE 137.SMITHS MEDICAL: PRODUCT PORTFOLIO
TABLE 138.TERUMO: COMPANY SNAPSHOT
TABLE 139.TERUMO: OERATING SEGMENT
TABLE 140.TERUMO: PRODUCT PORTFOLIO
Similar Reports
This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
